Adjuvanticity of an IL-12 fusion protein expressed by recombinant ΔG-vesicular stomatitis virus

Cellular Immunology

Volumn 218, Issue 1-2, 2002, Pages 59-73

  Klas, Sheri D ^a,b   Robison, Clinton S ^a   Whitt, Michael A ^a   Miller, Mark A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b GTx Inc   (United States)

Author keywords

Cytokines; IL 12; Immunity; Listeria monocytogenes; Th1 Th2 cells; Vaccination; VSV

Indexed keywords

BACTERIAL ANTIGEN; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENETIC CODE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; LISTERIOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; VESICULAR STOMATITIS VIRUS; VIRUS RECOMBINANT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, BACTERIAL; ASCITIC FLUID; BACTERIAL VACCINES; CELL LINE; CRICETINAE; DEFECTIVE VIRUSES; FEMALE; GENE DELETION; GENETIC VECTORS; IMMUNITY, CELLULAR; IMMUNIZATION; INTERLEUKIN-12; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LIVER; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; RECOMBINANT FUSION PROTEINS; SPLEEN; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS;

LISTERIA; LISTERIA MONOCYTOGENES; MURINAE; VECTORS; VESICULAR STOMATITIS VIRUS;

EID: 0036920034     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(02)00575-0     Document Type: Article

References (78)

1. T.R. Mosmann, R.L. Coffman, TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties, Annu. Rev. Immunol. 7 (1989) 145-173.
2. F.D. Finkelman, J. Holmes, I.M. Katona, J.F. Urban Jr., M.P. Beckmann, L.S. Park, K.A. Schooley, R.L. Coffman, T.R. Mosmann, W.E. Paul, Lymphokine control of in vivo immunoglobulin isotype selection, Annu. Rev. Immunol. 8 (1990) 303-333.
3. R.A. Seder, W.E. Paul, Acquisition of lymphokine-producing phenotype by CD4+ T cells, Annu. Rev. Immunol. 12 (1994) 635-673.
4. A.K. Abbas, K.M. Murphy, A. Sher, Functional diversity of helper T lymphocytes, Nature 383 (1996) 787-793.
5. G. Trinchieri, Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes, Blood 84 (1994) 4008-4027.
6. A. D'Andrea, M. Rengaraju, N.M. Valiante, J. Chehimi, M. Kubin, M. Aste, S.H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S.F. Wolf, G. Trinchieri, Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells, J. Exp. Med. 176 (1992) 1387-1398.
7. M.J. Skeen, M.A. Miller, T.M. Shinnick, H.K. Ziegler, Regulation of murine macrophage IL-12 production: Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines, J. Immunol. 156 (1996) 1196-1206.
8. S.E. Macatonia, N.A. Hosken, M. Litton, P. Vieira, C.S. Hsieh, J.A. Culpepper, M. Wysocka, G. Trinchieri, K.M. Murphy, A. O'Garra, Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells, J. Immunol. 154 (1995) 5071-5079.
9. M. Cella, D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, G. Alber, Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation, J. Exp. Med. 184 (1996) 747-752.
10. G. Trinchieri, M. Wysocka, A. D'Andrea, M. Rengaraju, A.M. Aste, M. Kubin, N.M. Valiante, J. Chehimi, Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation, Prog. Growth Factor Res. 4 (1992) 355-368.
11. G. Trinchieri, Interleukin-12 and its role in the generation of TH1 cells, Immunol. Today 14 (1993) 335-338.
12. +T cells through IL-12 produced by Listeria-induced macrophages, Science 260 (1993) 547-549.
13. +T cells to enhance priming for interferon gamma production and diminishes interleukin-4 inhibition of such priming, Proc. Natl. Acad. Sci. USA 90 (1993) 10188-10192.
14. R. Manetti, P. Parronchi, M.G. Giudizi, M.P. Piccinni, E. Maggi, G. Trinchieri, S. Romagnani, Natural killer cell stimulatory factor (interleukin-12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells, J. Exp. Med. 177 (1993) 1199-1204.
15. S.L. Reiner, R.M. Locksley, The regulation of immunity to Leishmania major, Annu. Rev. Immunol. 13 (1995) 151-177.
16. S. Rossol, G. Marinos, P. Carucci, M.V. Singer, R. Williams, N.V. Naoumov, Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B, J. Clin. Invest. 99 (1997) 3025-3033.
17. J.S. Orange, S.F. Wolf, C.A. Biron, Effects of IL-12 on the response and susceptibility to experimental viral infections, J. Immunol. 152 (1994) 1253-1264.
18. J.S. Orange, C.A. Biron, Characterization of early IL-12, IFN-αβ, TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection, J. Immunol. 156 (1996) 4746-4756.
19. J.A. Carr, J. Rogerson, M.J. Mulqueen, N.A. Roberts, R.F. Booth, Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections, J. Virol. 71 (1997) 7799-7803.
20. Z. Bi, P. Quandt, T. Komatsu, M. Barna, C.S. Reiss, IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system, J. Immunol. 155 (1995) 5684-5689.
21. W.G. Yu, M. Ogawa, J. Mu, K. Umehara, T. Tsujimura, H. Fujiwara, T. Hamaoka, IL-12-induced tumor regression correlates with in situ activity of IFN-γ produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways, J. Leukoc. Biol. 62 (1997) 450-457.
22. S. Dias, H. Thomas, F. Balkwill, Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model, Int. J. Cancer 75 (1998) 151-157.
23. A.L. Rakhmilevich, J. Turner, M.J. Ford, D. McCabe, W.H. Sun, P.M. Sondel, K. Grota, N.S. Yang, Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors, Proc. Natl. Acad. Sci. USA 93 (1996) 6291-6296.
24. M.A. Miller, M.J. Skeen, H.K. Ziegler, Long-lived protective immunity to Listeria is conferred by immunization with particulate or soluble listerial antigen preparations coadministered with IL-12, Cell Immunol. 184 (1998) 92-104.
25. M.A. Miller, M.J. Skeen, H.K. Ziegler, A synthetic peptide administered with IL-12 elicits immunity to Listeria monocytogenes, J. Immunol. 159 (1997) 3675-3679.
26. M.A. Miller, M.J. Skeen, H.K. Ziegler, Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes, J. Immunol. 155 (1995) 4817-4828.
27. J. Bliss, V. Van Cleave, K. Murray, A. Wiencis, M. Ketchum, R. Maylor, T. Haire, C. Resmini, A.K. Abbas, S.F. Wolf, IL-12, as an adjuvant, promotes a T helper1 cell, but does not suppress a T helper 2 cell recall response, J. Immunol. 156 (1996) 887-894.
28. T.A. Wynn, A. Reynolds, S. James, A.W. Cheever, P. Caspar, S. Hieny, D. Jankovic, M. Strand, A. Sher, IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite, J. Immunol. 157 (1996) 4068-4078.
29. L.C. Afonso, T.M. Scharton, L.Q. Vieira, M. Wysocka, G. Trinchieri, P. Scott, The adjuvant effect of interleukin-12 in a vaccine against Leishmania major, Science 263 (1994) 235-237.
30. D. Weiner, Plasmid interleukin 12, Aids 14 (2000) 1759-1760.
31. S.S. Ahuja, R.L. Reddick, N. Sato, E. Montalbo, V. Kostecki, W. Zhao, M.J. Dolan, P.C. Melby, S.K. Ahuja, Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection, J. Immunol. 163 (1999) 3890-3897.
32. L. Zitvogel, B. Couderc, J.I. Mayordomo, P.D. Robbins, M.T. Lotze, W.J. Storkus, IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo, Ann. N Y Acad. Sci. 795 (1996) 284-293.
33. M.M. Gherardi, J.C. Ramirez, D. Rodriguez, J.R. Rodriguez, G. Sano, F. Zavala, M. Esteban, IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner, J. Immunol. 162 (1999) 6724-6733.
34. L.A. Ball, C.N. White, Order of transcription of genes of vesicular stomatitis virus, Proc. Natl. Acad. Sci. USA 73 (1976) 442-446.
35. G. Abraham, A.K. Banerjee, Sequential transcription of the genes of vesicular stomatitis virus, Proc. Natl. Acad. Sci. USA 73 (1976) 1504-1508.
36. N.D. Lawson, E.A. Stillman, M.A. Whitt, J.K. Rose, Recombinant vesicular stomatitis viruses from DNA, Proc. Natl. Acad. Sci. USA 92 (1995) 4477-4481.
37. M.J. Schnell, L. Buonocore, E. Kretzschmar, E. Johnson, J.K. Rose, Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles, Proc. Natl. Acad. Sci. USA 93 (1996) 11359-11365.
38. K. Haglund, J. Forman, H.G. Krausslich, J.K. Rose, Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: High-level production of virus-like particles containing HIV envelope, Virology 268 (2000) 112-121.
39. M.J. Schnell, L. Buonocore, M.A. Whitt, J.K. Rose, The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus, J. Virol. 70 (1996) 2318-2323.
40. N.F. Rose, P.A. Marx, A. Luckay, D.F. Nixon, W.J. Moretto, S.M. Donahoe, D. Montefiori, A. Roberts, L. Buonocore, J.K. Rose, An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants, Cell 106 (2001) 539-549.
41. N.F. Rose, A. Roberts, L. Buonocore, J.K. Rose, Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1, J. Virol. 74 (2000) 10903-10910.
42. E.A. Stillman, J.K. Rose, M.A. Whitt, Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins, J. Virol. 69 (1995) 2946-2953.
43. A. Takada, C. Robison, H. Goto, A. Sanchez, K.G. Murti, M.A. Whitt, Y. Kawaoka, A system for functional analysis of Ebola virus glycoprotein, Proc. Natl. Acad. Sci. USA 94 (1997) 14764-14769.
44. G.J. Lieschke, P.K. Rao, M.K. Gately, R.C. Mulligan, Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo, Nat. Biotechnol. 15 (1997) 35-40.
45. C.S. Robison, M.A. Whitt, The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly, J. Virol. 74 (2000) 2239-2246.
46. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685.
47. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
48. J.A. Ledbetter, R.V. Rouse, H.S. Micklem, L.A. Herzenberg, T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views, J. Exp. Med. 152 (1980) 280-295.
49. P. Portoles, J. Rojo, A. Golby, M. Bonneville, S. Gromkowski, L. Greenbaum, C.A. Janeway Jr., D.B. Murphy, K. Bottomly, Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation, J. Immunol. 142 (1989) 4169-4175.
50. K.S. Hathcock, H. Hirano, S. Murakami, R.J. Hodes, CD45 expression by B cells. Expression of different CD45 isoforms by subpopulations of activated B cells, J. Immunol. 149 (1992) 2286-2294.
51. R.T. Kubo, W. Born, J.W. Kappler, P. Marrack, M. Pigeon, Characterization of a monoclonal antibody which detects all murine αβ T cell receptors, J. Immunol. 142 (1989) 2736-2742.
52. T. Goodman, L. Lefrancois, Intraepithelial lymphocytes. Anatomical site, not T cell receptor form, dictates phenotype and function, J. Exp. Med. 170 (1989) 1569-1581.
53. M.J. Skeen, H.K. Ziegler, Induction of murine peritoneal gamma/delta T cells and their role in resistance to bacterial infection, J. Exp. Med. 178 (1993) 971-984.
54. G.G. Frederickson, R.S. Basch, L3T4 antigen expression by hemopoietic precursor cells, J. Exp. Med. 169 (1989) 1473-1478.
55. J.A. Ledbetter, L.A. Herzenberg, Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens, Immunol. Rev. 47 (1979) 63-90.
56. G.L. Spitalny, E.A. Havell, Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities, J. Exp. Med. 159 (1984) 1560-1565.
57. H.C. Cherwinski, J.H. Schumacher, K.D. Brown, T.R. Mosmann, Two types of mouse helper T cell clone: 3. Further differences in lymphokine synthesis between TH1 and TH2 clones revealed by RNA hybridization, functionally monospecific bioassays and monoclonal antibodies, J. Exp. Med. 166 (1987) 1229-1244.
58. B. Sander, I. Hoiden, U. Andersson, E. Moller, J.S. Abrams, Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining, J. Immunol. Methods 166 (1993) 201-214.
59. S.A. Bogen, I. Fogelman, A.K. Abbas, Analysis of IL-2, IL-4, IFN-γ-producing cells in situ during immune responses to protein antigens, J. Immunol. 150 (1993) 4197-4205.
60. J.E. Coligan, A.M. Kruisbeek, D.M. Margulies, E.M. Shevach, W. Strober, Current Protocols in Immunology, Wiley, New York, 1991.
61. P.A. Wentworth, H.K. Ziegler, The antigenic and mitogenic response of murine T and B lymphocytes to soluble proteins of Listeria monocytogenes, J. Immunol. 138 (1987) 2671-2678.
62. H.K. Ziegler, C.A. Orlin, C.W. Cluff, Differential requirements for the processing and presentation of soluble and particulate bacterial antigens by macrophages, Eur. J. Immunol. 17 (1987) 1287-1296.
63. N.E. Marshall, H.K. Ziegler, Lipopolysaccharide responsiveness is an important factor in the generation of optimal antigen-specific T cell responses during infection with gram-negative bacteria, J. Immunol. 147 (1991) 2333-2339.
64. H. Karasuyama, F. Melchers, Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors, Eur. J. Immunol. 18 (1988) 97-104.
65. R.J. North, Cellular mediators of anti-Listeria immunity as an enlarged population of short lived, replicating T cells. Kinetics of their production, J. Exp. Med. 138 (1973) 342-355.
66. G.B. Mackaness, Cellular resistance to infection, J. Exp. Med. 116 (1962) 381-406.
67. S.H. Kaufmann, Immunity to intracellular bacteria, Annu. Rev. Immunol. 11 (1993) 129-163.
68. S.H. Gregory, L.K. Barczynski, E.J. Wing, Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infections, J. Leukoc. Biol. 51 (1992) 421-424.
69. G.B. Mackaness, W.C. Hill, The effect of anti-lymphocyte globulin on cell-mediated reistance to infection, J. Exp. Med. 129 (1969) 993-1012.
70. C.H. von Koenig, H. Finger, H. Hof, Failure of killed Listeria monocytogenes vaccine to produce protective immunity, Nature 297 (1982) 233-234.
71. P. Berche, J.L. Gaillard, P.J. Sansonetti, Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity, J. Immunol. 138 (1987) 2266-2271.
72. M.A. Miller, M.J. Skeen, H.K. Ziegler, Protective immunity to Listeria monocytogenes elicited by immunization with heat-killed Listeria and IL-12. Potential mechanism of IL-12 adjuvanticity, Ann. N Y Acad. Sci. 797 (1996) 207-227.
73. F. Martin, J.F. Kearney, B1 cells: Similarities and differences with other B cell subsets, Curr. Opin. Immunol. 13 (2001) 195-201.
74. D. Masopust, V. Vezys, A.L. Marzo, L. Lefrancois, Preferential localization of effector memory cells in nonlymphoid tissue, Science 291 (2001) 2413-2417.
75. B.L. Cline, Ecological associations of vesicular stomatitis virus in rural Central America and Panama, Am. J. Trop. Med. Hyg. 25 (1976) 875-883.
76. N.L. Letvin, Progress in the development of an HIV-1 vaccine, Science 280 (1998) 1875-1880.
77. J.M. Kelley, S.U. Emerson, R.R. Wagner, The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody, J. Virol. 10 (1972) 1231-1235.
78. E.J. Stott, L.A. Ball, K.K. Young, J. Furze, G.W. Wertz, Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge, J. Virol. 60 (1986) 607-613.